Publications by authors named "Natalie Compton"

Claim this Profile
A
A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO.
Melissa M Hardesty, Thomas C Krivak, Gail S Wright, Erika Hamilton, Evelyn L Fleming, Natalie Compton

Gynecol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary.
Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, Whitney Graybill, Domenica Lorusso, Natalie Compton

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
Bhavana Pothuri, Sileny Han, Dana M Chase, Florian Heitz, Robert A Burger, Natalie Compton

Gynecol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial.
Joyce F Liu, Stéphanie Gaillard, Andrea E Wahner Hendrickson, Oladapo Yeku, Elisabeth Diver, Natalie Compton

JCO Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free survival and safety at 3.5years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer.
Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, Whitney Graybill, Domenica Lorusso, Natalie Compton

Eur J Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials.
Hisham Mehanna, Natalie Franklin, Natalie Compton, Max Robinson, Ned Powell

Head Neck· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: a systematic review and meta-analysis of clinical trials in advanced cancer patients.
Thomas Powles, Sergio Bracarda, Mei Chen, Elliot Norry, Natalie Compton

Eur J Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors.
Kari L Kendra, Ruth Plummer, Ravi Salgia, Mary E R O'Brien, Elaine M Paul, Natalie Compton

Mol Cancer Ther· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease.
Kevin Harrington, Alain Berrier, Martin Robinson, Eva Remenar, Martin Housset, Natalie Compton

Eur J Cancer· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ecological research needs of business.
Paul R Armsworth, Anastasia N Armsworth, Natalie Compton, Phil Cottle, Ian Davies

J Appl Ecol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis